129 related articles for article (PubMed ID: 2405248)
1. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats.
Riddick DS; Park SS; Gelboin HV; Marks GS
Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248
[TBL] [Abstract][Full Text] [Related]
2. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
Riddick DS; Park SS; Gelboin HV; Marks GS
Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472
[TBL] [Abstract][Full Text] [Related]
3. Irreversible binding of heme to microsomal protein during inactivation of cytochrome P450 by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine.
Riddick DS; Marks GS
Biochem Pharmacol; 1990 Oct; 40(8):1915-21. PubMed ID: 2242024
[TBL] [Abstract][Full Text] [Related]
4. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
5. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
McNamee JP; Kimmett SM; Marks GS
Biochem Pharmacol; 1995 May; 49(10):1443-52. PubMed ID: 7763287
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents.
McCluskey SA; Riddick DS; Mackie JE; Kimmett SM; Whitney RA; Marks GS
Can J Physiol Pharmacol; 1992 Aug; 70(8):1069-74. PubMed ID: 1473038
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of rat liver microsomal steroid hydroxylations by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine: evidence for selectivity among steroid-inducible cytochrome P450IIIA forms.
Riddick DS; McGilvray I; Marks GS
Can J Physiol Pharmacol; 1990 Dec; 68(12):1533-41. PubMed ID: 2085799
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450 b and c in the rat brain and pituitary gland.
Näslund BM; Glaumann H; Warner M; Gustafsson JA; Hansson T
Mol Pharmacol; 1988 Jan; 33(1):31-7. PubMed ID: 3275864
[TBL] [Abstract][Full Text] [Related]
11. Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.
Correia MA; Decker C; Sugiyama K; Caldera P; Bornheim L; Wrighton SA; Rettie AE; Trager WF
Arch Biochem Biophys; 1987 Nov; 258(2):436-51. PubMed ID: 3674884
[TBL] [Abstract][Full Text] [Related]
12. 3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6.
Riddick DS; Mackie JE; Massey TE; Marks GS
Can J Physiol Pharmacol; 1990 Mar; 68(3):370-3. PubMed ID: 2322893
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of hepatic cytochrome P450 2C6 and P450 3A1 following in vivo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine to rats: differences from previously observed in vitro results.
Kimmett SM; McNamee JP; Marks GS
Can J Physiol Pharmacol; 1994 Apr; 72(4):397-401. PubMed ID: 7922872
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
Shiverick KT
Drug Metab Dispos; 1981; 9(6):545-50. PubMed ID: 6120814
[TBL] [Abstract][Full Text] [Related]
15. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
Kelley M; Hantelle P; Safe S; Levin W; Thomas PE
Mol Pharmacol; 1987 Aug; 32(1):206-11. PubMed ID: 3302669
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
[TBL] [Abstract][Full Text] [Related]
17. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
19. Olfactory cytochrome P-450. Studies with suicide substrates of the haemoprotein.
Reed CJ; Lock EA; De Matteis F
Biochem J; 1988 Jul; 253(2):569-76. PubMed ID: 3263118
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
Miller NE; Halpert JR
Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
